Head of Finance & Investor Relations (mfd)

Berlin On-site Full-time CFO track Fluent English required

At Cellbricks Therapeutics we work towards a future where humans can enjoy longer and healthier lives. Every 30 seconds a patient dies from a disease caused by tissue dysfunction. Our vision is to change that by producing bioengineered implantable human tissue that restores organ and tissue function for millions of patients.

Our mission is backed by visionary investors including ACT Ventures Partners Silicon RoundAbout Ventures and SPRIND Federal Agency for Breakthrough Innovation as well as key individual investors.

Cellbricks Therapeutics is a Berlin- and Boston-based biotech company developing bioengineered tissue therapeutics. We combine bioprinting tissue engineering and regenerative medicine to build functional human tissue at scale.

We are an interdisciplinary team of biotechnologists engineers chemists and entrepreneurs from more than 14 nations united by a proactive hands-on approach to solving hard scientific problems. Our team is currently advancing multiple therapeutic programmes focused on the restoration of complex wounds and organ failure towards pre-IND and IND milestones in collaboration with leading clinical pharmaceutical and manufacturing partners. Currently we are preparing for our next major stage of development and Series-A financing.

We are looking for a finance leader who will help build the financial backbone for that stage and play a central role in preparing and executing an ambitious international Series A with leading investors.

Work closely with our Co-CEOs leadership team fractional CFO and external finance specialists to progressively bring financial planning controlling reporting and investor relations further inside Cellbricks. Translate scientific operational and commercial plans into a credible financing story ensuring readiness for investor due diligence and execution. You will help establish the financial insight systems and decision-making discipline required to scale Cellbricks successfully.

Finance & financial planning

• Budgeting forecasting liquidity planning & runway management.
• Integrated financial models financing scenarios use-of-funds planning & performance tracking.
• Coordination of accounting payroll tax audit grant reimbursement & external providers; continuous improvement of systems controls & data quality.

Series A investor relations & board

• Financial preparation & execution of the international Series A incl. investor materials data-room readiness transaction workstreams & the equity story.
• Investor reporting shareholder communication financial Q&A & trusted working relationships with investors.
• Board agendas materials financial presentations management inputs & follow-up of decisions & commitments.

Building the internal finance function

• Initially work alongside an experienced fractional CFO
  & external finance team benefiting from proven processes & structured onboarding.
• Assume broader ownership over time & build a
  scalable in-house finance and investor-relations function with a credible path toward Finance Director / VP Finance & potentially CFO responsibility.

• Meaningful hands-on ownership in a substantial institutional financing ideally a successful Series A.
• Typically 5 years in finance corporate finance transaction advisory or investor relations.
• Strong modelling budgeting & forecasting skills plus a working understanding of German accounting tax & corporate-finance fundamentals.
• Strategic and hands-on with independent judgment strong communication & credibility across management investors & board.
• Fluent English; German highly desirable.

• Deep-tech or another R&D-intensive environment;
  ideally biotech life sciences medtech.
• International investors particularly from Europe & US.
• International group structures especially cross-border intercompany acc. financing or transfer-pricing involving German & US entities.
• Grant-funded R&D non-dilutive financing board reporting or internalizing a finance function

• Build a central role in building a deep-tech-rooted biotech company.
• Shape adefining role in the international Series A with European and US investor exposure.
• Grow with structured support meaningful stock options and a credible path to CFO.
• Have a real impact on the future of medicine through the development of bioengineered tissue therapeutics.
• Work with a fantastic international and interdisciplinary team.

• Competitive salary and benefits including Urban Sports the Deutschlandticket and a 50 voucher.
• Stock options.
• 30 days of annual leave.
• Regular team events.

This role is based in Berlin Germany within our management team.

Apply now we look forward to hearing from you. Send your CV cover letter including
brief answers on your largest financing your personal role and why Cellbricks.